← Back to Search

Health Information Technology for Dementia Care

N/A

Waitlist Available

Research Sponsored by Florida International University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

21 years-old or older

Care recipients must be 60 years or older

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 6 months, 12 months

Awards & highlights

Study Summary

This trial will develop and design a personalized AAC device that relies on information technology (IT) and touchscreens to promote communication and personhood for PWD about their care preferences and experiences.

Who is the study for?

This trial is for adults over 21 who care for someone with Alzheimer's or dementia, providing at least 2 hours of daily care. Participants must have internet access and speak English or Spanish. It includes people with neurocognitive disorders aged 60+, scoring ≤21 on a mental status exam, but excludes caregivers planning to quit soon, those caring for individuals in facilities, or anyone with major medical conditions themselves.Check my eligibility

What is being tested?

The study tests an Assistive and Alternative Communication (AAC) device integrated into the CareHeroes health IT system to enhance communication between patients with dementia, their caregivers, and healthcare providers over a period of 12 months.See study design

What are the potential side effects?

Since this intervention involves information technology rather than medication, traditional side effects are not expected. However, participants may experience challenges related to using new technology or emotional impacts from changes in communication patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 21 years old or older.

Select...

I am 60 years old or older.

Select...

I am a caregiver and I speak English or Spanish.

Select...

I have been diagnosed with a brain function disorder.

Select...

I can speak and understand English or Spanish.

Select...

I can complete the vision screening test.

Select...

I can speak and understand either English or Spanish.

Select...

I can speak and understand either English or Spanish.

Select...

I am 60 years old or older.

Select...

I have been diagnosed with a specific type of dementia.

Select...

I provide daily care for someone with Alzheimer's or dementia for 2+ hours.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 6 months, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 6 months, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Perceived Change Index- Caregiver QOL

Change in Quality of Life In Alzheimer's disease- Care Recipient and Caregiver (proxy-interview)

Secondary outcome measures

CareHeroes Usage - Links clicked on the app, resources accessed

CareHeroes Usage- Links clicked on the app, resources accessed

Change in 12 Item Short-Form Health Survey (SF-12) - Caregiver

+9 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Full InterventionExperimental Treatment1 Intervention

TRIADs (caregiver, PWD, and provider) randomly assigned to the experimental arm will have access to use CareHeroes AND the newly developed AAC app. Provider will receive information via the AAC app.

Group II: Minimal InterventionActive Control1 Intervention

TRIADs (caregiver, PWD, and provider) randomly assigned to the minimal intervention arm will have access to use CareHeroes but only a paper version of the newly developed AAC app.

0 / 11Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH

1,668 Previous Clinical Trials

28,004,944 Total Patients Enrolled

University of Alabama, TuscaloosaOTHER

44 Previous Clinical Trials

19,396 Total Patients Enrolled

Florida International UniversityLead Sponsor

99 Previous Clinical Trials

17,185 Total Patients Enrolled

Media Library

Integration of Health Information Technology and Promotion of Personhood in Family-Centered Dementia Care Clinical Trial Eligibility Overview. Trial Name: NCT04571502 — N/A

Neurocognitive Disorder Research Study Groups: Full Intervention, Minimal Intervention

Neurocognitive Disorder Clinical Trial 2023: Integration of Health Information Technology and Promotion of Personhood in Family-Centered Dementia Care Highlights & Side Effects. Trial Name: NCT04571502 — N/A

Integration of Health Information Technology and Promotion of Personhood in Family-Centered Dementia Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04571502 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any restrictions for participants in this trial?

"The research demands 120 individuals with Alzheimer's, aged between 21 and 99. To qualify for the experiment, applicants must fulfil a range of criteria: they must be at least 21 years old; have access to healthcare services that support PWDs and their families; be over 60 years old; acquire a Mini Mental Status Exam score of no greater than twenty-one points; possess regular internet connectivity via either laptop or smartphone as well as telephone service."

Answered by AI

Is registration available for this research endeavor?

"This research, which was initially made available on September 1st 2023 and last updated on October 5th 2022, is not presently recruiting. However, there are 813 other medical trials currently in need of patient volunteers at this time."

Answered by AI

What goals is this experimental program striving to attain?

"The aim of this research project, which will be evaluated at the Baseline, 6-months and 12-months intervals is to assess a Perceived Change Index – Caregiver QOL. Secondary aims comprise surveys with participating healthcare providers on their perceptions of incorporating CareHeroes into clinical operations such as acceptability of technology, difficulties encountered and observed advantages; exploring how the use of CH influenced medical/shared decision making and caregiving. Other secondary objectives involve evaluating depression severity by means of The Cornell Scale for Depression in Dementia (CSDD), interviews with caregivers about recipients’ wellbeing plus tracking user activities (provider, caregiver"

Answered by AI

Is the population of this research study restricted to those under 60 years old?

"For this clinical trial, individuals aged 21 to 99 are eligible. Meanwhile, those under 18 and over 65 have 38 and 800 trials respectively that they can take part in."

Answered by AI